Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,661.4
-28.2 (-1.05%)

 

  • STI Straits Times Index
    2,661.4
    -28.2 (-1.05%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.7
    -10.2 (-0.65%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,975.7
    -363.5 (-1.38%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,345.3
    12.5 (0.37%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,614.7
    -99.8 (-0.44%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,987.1
    -1.8 (-0.04%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,130.4M
  • Value: 1,221.0M
  • Rise: 124
  • Fall: 237
  • Unch: 447

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.002+0.001
MDR0.001-
Spackman0.011+0.001
CSE Global0.460+0.015
Medtecs Intl0.705+0.055
AsiaMedic0.015+0.003
Singapore-eDev0.119-
Secura0.101+0.006
IPS Securex0.118+0.011
Rex Intl0.180-0.005

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 07 Jul 2020 17:15
Last (SGD): 0.705 Change: +0.055 High: 0.770 Remarks: -
Change (%): +8.46 Low: 0.650
Open 0.685 Yesterday's Close 0.650
Buy Price 0.705 Sell Price 0.710
Buy Volume ('000) 643.5 Sell Volume ('000) 293.7
Cumulative Volume ('000) 109,380.3 Cumulative Value 76,785,808
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.00285 NAV (SGD) b 0.1559
PE a 247.368 Trailing PE f 247.498 Price / NAV b 4.5221
Dividend (SGD) d - Cash In Hand (SGD) g 0.0075 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 94.000 Treasury Shares h -
Beta - 75 Daysi 0.249 R-Squared - 75 Days(%)i 0.03 Market Cap (M) 387.335
Beta - 500 Daysi -0.266 R-Squared - 500 Days (%)i 0.11 Enterprise Value (M) 440.035
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 124.5078 6-Month VWAP 0.173 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 387.335 247.368 247.498 4.5221 -
Industry Medical & Biotechnology SGX 968.901 20.776 22.798 1.3222 2.041
Medical Specialties SGX 3,102.742 158.764 89.039 14.4740 0.342
Index FTSE ST Catalist Index SGX 74.719 30.063 88.683 0.9173 1.916
Local Peer Top Glove SGX 17,780.730 145.889 83.020 16.2043 0.355
Local Peer UG Healthcare SGX 305.905 122.066 150.396 7.2022 0.164
Local Peer Biolidics SGX 82.013 - - 7.5359 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 164,449.984 44.858 46.468 5.4421 1.415
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 150,977.919 40.849 41.150 5.2865 0.201
Global Peer DANAHER CORP NYSE 129,645.801 52.092 47.368 4.4014 0.365
Global Peer MEDTRONIC PLC NYSE 125,022.573 26.106 26.106 2.4641 2.317
Global Peer BECTON DICKINSON & CO NYSE 71,002.985 65.622 78.025 3.3893 1.181
Global Peer STRYKER CORP NYSE 68,930.869 33.092 31.853 5.2559 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 68,179.548 49.431 49.181 8.0148 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,848.501 10.819 11.861 3.6836 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,833.540 44.789 43.911 5.8233 0.960
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,889.623 33.602 33.602 3.1039 1.869
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), TOPGLOV (Bursa), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), AK MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), SUPERMX (Bursa), NUVASIVE INC (NASDAQ), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), KDL MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), LIFETECH SCI (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), INMODE LTD (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), ZYNEX INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CIRC (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SI BONE INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NYSE American), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), VIEWRAY INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), FLUIDIGM CORP DEL (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ALPHA PRO TECH (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), CUTERA INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), DERMTECH INC (NASDAQ), TELA BIO INC (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), VINCENT MED (HKEx), APYX MEDICAL CORPORATION (NASDAQ), SOLITON INC (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), TITAN MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), SENSUS HEALTHCARE INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), KELFRED (HKEx), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), DELCATH SYSTEMS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), REWALK ROBOTICS LTD (NASDAQ), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), LIFE HEALTHCARE (HKEx), AKERS BIOSCIENCES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), BIOLASE INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), CARDIEX LTD (ASX), CYANOTECH CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), STHAI (SET), DORSAVI LTD (ASX), ENDOLOGIX INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.325
+85.53 %
10 Days -+0.395
+127.42 %
20 Days -+0.470
+200.00 %
Medium Term Return 3 Months -+0.606
+612.12 %
6 Months -+0.657
+1368.75 %
1 Year -+0.676
+2331.03 %
Long Term Return 2 Years -+0.668
+1805.41 %
3 Years -+0.657
+1368.75 %
5 Years -+0.651
+1205.56 %
Annualised Return Annualised --
+67.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.025 - 0.770 Change From 1 Year Low +0.680 % Change From 1 Year Low (%) +2720.00
Change From 1 Year High -0.065 % Change From 1 Year High (%) -8.44
2 Years Range 0.022 - 0.770 Change From 2 Years Low +0.683 % Change From 2 Years Low (%) +3104.55
Change From 2 Years High -0.065 % Change From 2 Years High (%) -8.44
5 Years Range 0.022 - 0.770 Change From 5 Years Low +0.683 % Change From 5 Years Low (%) +3104.55
Change From 5 Years High -0.065 % Change From 5 Years High (%) -8.44
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +180.88 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
07 Jul 2020 0.685 0.770 0.650 0.705 109,380,300 0.7020
06 Jul 2020 0.535 0.655 0.530 0.650 80,881,000 0.5799
03 Jul 2020 0.465 0.525 0.460 0.500 98,205,600 0.4914
02 Jul 2020 0.415 0.475 0.415 0.465 80,356,300 0.4504
01 Jul 2020 0.390 0.420 0.390 0.410 53,623,900 0.4077
30 Jun 2020 0.365 0.400 0.365 0.380 67,120,500 0.3851
29 Jun 2020 0.335 0.375 0.335 0.365 50,310,400 0.3567
26 Jun 2020 0.350 0.350 0.335 0.340 35,380,000 0.3434
25 Jun 2020 0.310 0.345 0.310 0.345 48,746,700 0.3275
24 Jun 2020 0.315 0.325 0.305 0.310 25,605,600 0.3160
23 Jun 2020 0.300 0.320 0.295 0.310 39,154,900 0.3093
22 Jun 2020 0.300 0.310 0.290 0.300 14,095,600 0.2995
19 Jun 2020 0.330 0.335 0.295 0.295 68,058,100 0.3162
18 Jun 2020 0.275 0.325 0.275 0.320 106,305,600 0.3026
17 Jun 2020 0.280 0.280 0.270 0.275 6,953,900 0.2752
16 Jun 2020 0.280 0.285 0.270 0.280 15,140,100 0.2777
15 Jun 2020 0.280 0.290 0.270 0.270 33,928,500 0.2800
12 Jun 2020 0.255 0.285 0.255 0.275 45,854,200 0.2748
11 Jun 2020 0.275 0.290 0.260 0.260 62,356,800 0.2755
10 Jun 2020 0.240 0.275 0.240 0.275 49,182,500 0.2607
09 Jun 2020 0.245 0.250 0.230 0.235 20,510,900 0.2405
08 Jun 2020 0.250 0.255 0.240 0.240 21,067,800 0.2469
Summary
Current 2 Weeks
(24 Jun 2020 to 07 Jul 2020)
0.315 0.770 0.305 0.705 649,610,300 -
Previous 2 Weeks
(10 Jun 2020 to 23 Jun 2020)
0.240 0.770 0.240 0.310 441,030,200 -
4 Weeks from
(12 May 2020 to 09 Jun 2020)
0.178 0.770 0.172 0.235 864,865,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.